Literature DB >> 33369718

Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence.

Eyob Alemayehu Gebreyohannes1, Sandra Salter2, Leanne Chalmers3, Luke Bereznicki4, Kenneth Lee2,4.   

Abstract

Atrial fibrillation is the most common arrhythmia. It increases the risk of thromboembolism by up to fivefold. Guidelines provide evidence-based recommendations to effectively mitigate thromboembolic events using oral anticoagulants while minimizing the risk of bleeding. This review focuses on non-adherence to contemporary guidelines and the factors associated with guideline non-adherence. The extent of guideline non-adherence differs according to geographic region, healthcare setting, and risk stratification tools used. Guideline adherence has gradually improved over recent years, but a significant proportion of patients are still not receiving guideline-recommended therapy. Physician-related and patient-related factors (such as patient refusals, bleeding risk, older age, and recurrent falls) also contribute to guideline non-adherence, especially to undertreatment. Quality improvement initiatives that focus on undertreatment, especially in the primary healthcare setting, may help to improve guideline adherence.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33369718     DOI: 10.1007/s40256-020-00457-3

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN: 1175-3277            Impact factor:   3.571


  82 in total

1.  Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.

Authors:  J B Segal; R L McNamara; M R Miller; N Kim; S N Goodman; N R Powe; K A Robinson; E B Bass
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

Review 2.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2019-01-28       Impact factor: 29.690

3.  National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018.

Authors:  David Brieger; John Amerena; John Attia; Beata Bajorek; Kim H Chan; Cia Connell; Ben Freedman; Caleb Ferguson; Tanya Hall; Haris Haqqani; Jeroen Hendriks; Charlotte Hespe; Joseph Hung; Jonathan M Kalman; Prashanthan Sanders; John Worthington; Tristan D Yan; Nicholas Zwar
Journal:  Heart Lung Circ       Date:  2018-10       Impact factor: 2.975

4.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

Review 5.  The Epidemiology of Atrial Fibrillation and Stroke.

Authors:  Francesca Pistoia; Simona Sacco; Cindy Tiseo; Diana Degan; Raffaele Ornello; Antonio Carolei
Journal:  Cardiol Clin       Date:  2016-03-18       Impact factor: 2.213

6.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Authors:  Jan Steffel; Peter Verhamme; Tatjana S Potpara; Pierre Albaladejo; Matthias Antz; Lien Desteghe; Karl Georg Haeusler; Jonas Oldgren; Holger Reinecke; Vanessa Roldan-Schilling; Nigel Rowell; Peter Sinnaeve; Ronan Collins; A John Camm; Hein Heidbüchel
Journal:  Eur Heart J       Date:  2018-04-21       Impact factor: 29.983

Review 7.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

Authors:  Jocasta Ball; Melinda J Carrington; John J V McMurray; Simon Stewart
Journal:  Int J Cardiol       Date:  2013-02-04       Impact factor: 4.164

8.  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.

Authors:  Gregory Y H Lip; Amitava Banerjee; Giuseppe Boriani; Chern En Chiang; Ramiz Fargo; Ben Freedman; Deirdre A Lane; Christian T Ruff; Mintu Turakhia; David Werring; Sheena Patel; Lisa Moores
Journal:  Chest       Date:  2018-08-22       Impact factor: 9.410

9.  Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring.

Authors:  Wolfgang Mueck; Stephan Schwers; Jan Stampfuss
Journal:  Thromb J       Date:  2013-06-28

Review 10.  2018 Korean Guideline of Atrial Fibrillation Management.

Authors:  Boyoung Joung; Jung Myung Lee; Ki Hong Lee; Tae Hoon Kim; Eue Keun Choi; Woo Hyun Lim; Ki Woon Kang; Jaemin Shim; Hong Euy Lim; Junbeom Park; So Ryoung Lee; Young Soo Lee; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-12       Impact factor: 3.243

View more
  4 in total

1.  Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation.

Authors:  Jose Miguel Calderon; Fernando Martinez; Javier Diaz; Antonio Fernandez; Inmaculada Sauri; Ruth Uso; Jose Luis Trillo; Sara Vela; Carlos Bea; Josep Redon; Maria Jose Forner
Journal:  Front Cardiovasc Med       Date:  2022-01-21

2.  Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.

Authors:  José Maria Farinha; Ian D Jones; Gregory Y H Lip
Journal:  Eur Heart J Suppl       Date:  2022-02-14       Impact factor: 1.803

3.  Efficacy and Safety of Catheter Ablation Combined with Left Atrial Appendage Closure in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  An Wang; Jingbo Jiang; Zhitao Xie; Guoqiang Zhong
Journal:  Anatol J Cardiol       Date:  2022-03       Impact factor: 1.475

4.  Use of thromboprophylaxis guidelines and risk stratification tools in atrial fibrillation: A survey of general practitioners in Australia.

Authors:  Eyob Alemayehu Gebreyohannes; Sandra M Salter; Leanne Chalmers; Jan Radford; Kenneth Lee
Journal:  J Eval Clin Pract       Date:  2022-04-06       Impact factor: 2.336

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.